Nikolaus Johannes Stiefl

Person

Lorrach, DE

People

Patents Grantslast 30 patents

Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,168,012
- Issue date Dec 17, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,139,471
- Issue date Nov 12, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 11,254,653
- Issue date Feb 22, 2022
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 11,208,399
- Issue date Dec 28, 2021
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridinone derivatives and their use as selective ALK-2 inhibitors
- Patent number 11,160,797
- Issue date Nov 2, 2021
- Novartis AG
- Luca Arista
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
- Patent number 10,947,218
- Issue date Mar 16, 2021
- Novartis AG
- Luca Arista
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
- Patent number 10,710,980
- Issue date Jul 14, 2020
- Novartis AG
- Luca Arista
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4...
- Patent number 9,079,897
- Issue date Jul 14, 2015
- Novartis AG
- Catherine Leblanc
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl benzylamine compounds
- Patent number 8,791,100
- Issue date Jul 29, 2014
- Novartis AG
- Daniela Angst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Organic compounds
- Patent number 8,431,578
- Issue date Apr 30, 2013
- Novartis AG
- Peter Hunt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Organic compounds
- Patent number 8,367,662
- Issue date Feb 5, 2013
- Novartis AG
- Duncan Shaw
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrimidines and pyrrolopyridines
- Patent number 8,314,112
- Issue date Nov 20, 2012
- Novartis AG
- Catherine Leblanc
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine derivatives as alk-5 inhibitors
- Patent number 7,989,458
- Issue date Aug 2, 2011
- Novartis AG
- Catherine Leblanc
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20220251067
- Publication date Aug 11, 2022
- Novartis AG
- Christopher FARADY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20210308140
- Publication date Oct 7, 2021
- Novartis AG
- Christopher FARADY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS
- Publication number 20210155606
- Publication date May 27, 2021
- Novartis AG
- Luca ARISTA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20200361899
- Publication date Nov 19, 2020
- Novartis AG
- Christopher FARADY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyridinone derivatives and their use as selective ALK-2 inhibitors
- Publication number 20200360357
- Publication date Nov 19, 2020
- Novartis AG
- Luca Arista
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20200361898
- Publication date Nov 19, 2020
- Novartis AG
- Christopher FARADY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS
- Publication number 20200299265
- Publication date Sep 24, 2020
- Novartis AG
- Luca ARISTA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS
- Publication number 20190161474
- Publication date May 30, 2019
- Novartis AG
- Luca ARISTA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARYL BENZYLAMINE COMPOUNDS
- Publication number 20110190258
- Publication date Aug 4, 2011
- Novartis AG
- Daniela ANGST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Organic Compounds
- Publication number 20100210641
- Publication date Aug 19, 2010
- Duncan Shaw
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic compounds as antiinflammatory agents
- Publication number 20100041662
- Publication date Feb 18, 2010
- Sandrine Ferrand
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine derivatives as alk-5 Inhibitors
- Publication number 20090209539
- Publication date Aug 20, 2009
- Catherine Leblanc
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrrolopyrimidines and Pyrrolopyridines
- Publication number 20090181941
- Publication date Jul 16, 2009
- Catherine Leblanc
- C07 - ORGANIC CHEMISTRY

Nikolaus Johannes Stiefl

Person

Patents Grantslast 30 patents

NLRP3 inflammasome inhibitors

NLRP3 inflammasome inhibitors

NLRP3 inflammasome inhibitors

NLRP3 inflammasome inhibitors

Pyridinone derivatives and their use as selective ALK-2 inhibitors

Aminopyridine derivatives and their use as selective ALK-2 inhibitors

Aminopyridine derivatives and their use as selective ALK-2 inhibitors

Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4...

Aryl benzylamine compounds

Organic compounds

Organic compounds

Pyrrolopyrimidines and pyrrolopyridines

Pyrimidine derivatives as alk-5 inhibitors

Patents Applicationslast 30 patents

NLRP3 INFLAMMASOME INHIBITORS

NLRP3 INFLAMMASOME INHIBITORS

AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS

NLRP3 INFLAMMASOME INHIBITORS

Pyridinone derivatives and their use as selective ALK-2 inhibitors

NLRP3 INFLAMMASOME INHIBITORS

AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS

AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS

ARYL BENZYLAMINE COMPOUNDS

Organic Compounds

Heterocyclic compounds as antiinflammatory agents

Pyrimidine derivatives as alk-5 Inhibitors

Pyrrolopyrimidines and Pyrrolopyridines